| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| David Platt | CEO, Director, 10%+ Owner | $12,882,399 | 25 Oct 2024 | ||
| Michael Sheikh | CCO, 10%+ Owner | $4,477,022 | 25 Oct 2024 | ||
| Binder Offer | 10%+ Owner | $1,721,400 | 31 Dec 2021 | ||
| Alan M. Hoberman | Director | $145,672 | 12 Aug 2025 | ||
| Dale H. Conaway | Director | $132,711 | 12 Aug 2025 | ||
| Anders Utter | Director | $130,402 | 14 Nov 2025 | ||
| Radka Milanova | Director | $71,290 | 12 Aug 2025 | ||
| Ola Soderquist | CFO, 10%+ Owner | $69,882 | 25 Oct 2024 | ||
| Hana Chen-Walden | Director | 31 Dec 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alan M. Hoberman | BIXT | common | Purchase | 210,000 | 210,000 | 18 Nov 2025 | Direct | |||
| Alan M. Hoberman | BIXT | preferred | Award | 10.2% | 38,588 | 416,207 | 14 Nov 2025 | Direct | ||
| Radka Milanova | BIXT | preferred | Award | 23.4% | 38,588 | 203,688 | 14 Nov 2025 | Direct | ||
| Dale H. Conaway | BIXT | preferred | Award | 11.3% | 38,588 | 379,177 | 14 Nov 2025 | Direct | ||
| Anders Utter | BIXT | preferred | Award | 11.6% | 38,588 | 372,580 | 14 Nov 2025 | Direct | ||
| Alan M. Hoberman | BIXT | preferred | Award | 2.84% | 10,417 | 377,619 | 12 Aug 2025 | Direct | ||
| Radka Milanova | BIXT | preferred | Award | 6.73% | 10,417 | 165,100 | 12 Aug 2025 | Direct | ||
| Dale H. Conaway | BIXT | preferred | Award | 3.16% | 10,417 | 340,589 | 12 Aug 2025 | Direct | ||
| Radka Milanova | BIXT | Preferred | Award | 170.7% | 97,535 | 154,683 | 06 Jan 2025 | Direct | ||
| Dale H. Conaway | BIXT | Preferred | Award | 41.9% | 97,535 | 330,172 | 06 Jan 2025 | Direct | ||
| Alan M. Hoberman | BIXT | Preferred | Award | 36.2% | 97,535 | 367,202 | 06 Jan 2025 | Direct | ||
| Anders Utter | BIXT | preferred | Award | 41.2% | 97,535 | 333,992 | 06 Jan 2025 | Direct | ||
| Michael Sheikh | BIXT | preferred | Other | 413.4% | 6,614,720 | 8,214,720 | 25 Oct 2024 | Direct | ||
| Ola Soderquist | BIXT | common | Other | 500,000 | 500,000 | 25 Oct 2024 | Direct | |||
| Ola Soderquist | BIXT | preferred | Other | 267.1% | 10,169,396 | 13,976,456 | 25 Oct 2024 | Direct | ||
| Radka Milanova | BIXT | preferred | Award | 56.4% | 20,619 | 57,148 | 25 Oct 2024 | Direct | ||
| David Platt | BIXT | Preferred | Other | 130% | 11,190,077 | 19,795,532 | 25 Oct 2024 | Direct | ||
| David Platt | BIXT | Preferred | Other | -100% | -14,085,410 | 0 | 25 Oct 2024 | through NDPD Pharma | ||
| Anders Utter | BIXT | preferred | Award | 9.55% | 20,619 | 236,457 | 25 Oct 2024 | Direct | ||
| Dale H. Conaway | BIXT | preferred | Award | 9.73% | 20,619 | 232,637 | 25 Oct 2024 | Direct | ||
| Ola Soderquist | BIXT | common | Other | 500,000 | 500,000 | 25 Oct 2024 | Direct | |||
| Ola Soderquist | BIXT | preferred | Other | -0.71% | -100,000 | 14,004,671 | 25 Oct 2024 | Direct | ||
| Ola Soderquist | BIXT | preferred | Other | 261% | 10,197,611 | 14,104,671 | 25 Oct 2024 | Direct | ||
| Alan M. Hoberman | BIXT | preferred | Award | 8.28% | 20,619 | 269,667 | 25 Oct 2024 | Direct | ||
| David Platt | BIXT | preferred | Other | 132.9% | 11,433,448 | 20,038,903 | 24 Oct 2024 | Direct | ||
| David Platt | BIXT | preferred | Other | -100% | -14,085,410 | 0 | 24 Oct 2024 | through NDPD Pharma | ||
| Michael Sheikh | BIXT | Preferred | Other | 404.6% | 6,473,921 | 8,073,921 | 24 Oct 2024 | Direct | ||
| Ola Soderquist | BIXT | preferred | Other | 3,907,060 | 3,907,060 | 19 Aug 2024 | Direct | |||
| Ola Soderquist | BIXT | common | Other | -100% | -19,535,300 | 0 | 19 Aug 2024 | Direct | ||
| Michael Sheikh | BIXT | preferred | Other | 1,600,000 | 1,600,000 | 19 Aug 2024 | Direct | |||
| Michael Sheikh | BIXT | common | Other | -100% | -8,000,000 | 0 | 19 Aug 2024 | Direct | ||
| Radka Milanova | BIXT | preferred | Other | 36,529 | 36,529 | 19 Aug 2024 | Direct | |||
| Radka Milanova | BIXT | common | Other | -100% | -182,645 | 0 | 19 Aug 2024 | Direct | ||
| David Platt | BIXT | preferred | Other | 8,605,455 | 8,605,455 | 19 Aug 2024 | Direct | |||
| David Platt | BIXT | common | Other | -100% | -43,027,274 | 0 | 19 Aug 2024 | Direct | ||
| David Platt | BIXT | preferred | Other | 82,260 | 82,260 | 19 Aug 2024 | by Naomi Platt | |||
| David Platt | BIXT | common | Other | -100% | -411,300 | 0 | 19 Aug 2024 | by Naomi Platt | ||
| David Platt | BIXT | preferred | Conversion of derivative security | 207% | 8,973,405 | 13,308,593 | 19 Aug 2024 | by NDPD Pharma | ||
| David Platt | BIXT | preferred | Other | 57% | 5,112,005 | 14,085,410 | 19 Aug 2024 | by NDPD Pharma | ||
| David Platt | BIXT | common | Other | -100% | -21,675,939 | 0 | 19 Aug 2024 | by NDPD Pharma | ||
| Anders Utter | BIXT | preferred | Other | 215,838 | 215,838 | 19 Aug 2024 | Direct | |||
| Anders Utter | BIXT | common | Other | -100% | -1,079,189 | 0 | 19 Aug 2024 | Direct | ||
| Dale H. Conaway | BIXT | preferred | Other | 212,018 | 212,018 | 19 Aug 2024 | Direct | |||
| Dale H. Conaway | BIXT | common | Other | 1,060,089 | 0 | 19 Aug 2024 | Direct | |||
| Alan M. Hoberman | BIXT | preferred | Other | 226,678 | 226,678 | 19 Aug 2024 | Direct | |||
| Alan M. Hoberman | BIXT | common | Other | -100% | -1,133,389 | 0 | 19 Aug 2024 | Direct | ||
| Radka Milanova | BIXT | common | Award | 82.6% | 82,645 | 182,645 | 16 Aug 2024 | Direct | ||
| Anders Utter | BIXT | common | Award | 13% | 123,967 | 1,079,189 | 16 Aug 2024 | Direct | ||
| Dale H. Conaway | BIXT | common | Award | 13.2% | 123,967 | 1,060,089 | 16 Aug 2024 | Direct | ||
| Alan M. Hoberman | BIXT | common | Award | 12.3% | 123,967 | 1,133,389 | 16 Aug 2024 | Direct |